Dexrazoxane for Cardiac Protection Against Doxorubicin
Dexrazoxane (Zinecard - Pharmacia) was recently approved by the US Food and Drug Administration (FDA) for protection against cardiac toxicity from (Adriamycin, and others) in women with metastatic breast cancer....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Dexrazoxane for Cardiac Protection Against Doxorubicin
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 962
Article Code: 962b
Date: November 24, 1995
Volume: 37
Pages: 110-111
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 962
Article Code: 962b
Date: November 24, 1995
Volume: 37
Pages: 110-111
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)